This is the authors' abstract. We don't add key points for this paper.
Apple pomace (AP) is an underutilized bio-residue of the fruit processing industry with outstanding potential for conversion into bio-based ingredients. To assess its potential as a functional ingredient, a comparative in vitro digestion study (focusing phenolic bioaccessibility and prebiotic activity) was conducted using AP and its hydroethanolic extract (HE_AP). AP presented high concentrations of dietary fiber, organic acids, unsaturated fatty acids, and phenolic compounds, including both free and bound forms. Bioaccessibility studies demonstrated a dual release profile: HE_AP enabled a rapid release of phenolic compounds in the upper gastrointestinal tract (phenolics after digestion 364 ± 10 mg/100 g dw); whole AP ensured a gradual and sustained release of bioactive metabolites in the colon (64 ± 1 mg/100 g dw). Likewise, AP effectively promoted the growth of beneficial probiotic strains ( Lactobacillus and Bifidobacterium ), demonstrating its potential as a multifunctional ingredient to support gut health. These results promote the incorporation of AP into innovative and sustainable food and nutraceutical formulations.
No takes yet. Share an insight, caveat, or question.
Pascoalino et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: